Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Apr;44(4):281-4.
doi: 10.1136/jmg.2006.046425. Epub 2006 Nov 10.

Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia

Comparative Study

Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia

Christel Depienne et al. J Med Genet. 2007 Apr.

Abstract

Background: Point mutations in SPG4, the gene encoding spastin, are a frequent cause of autosomal dominant hereditary spastic paraplegia (AD-HSP). However, standard methods for genetic analyses fail to detect exonic microdeletions.

Methods: 121 mutation-negative probands were screened for rearrangements in SPG4 by multiplex ligation-dependent probe amplification.

Results: 24 patients with 16 different heterozygotic exon deletions in SPG4 (20%) were identified, ranging from one exon to the whole coding sequence. Comparison with 78 patients with point mutations showed a similar clinical picture but an earlier age at onset.

Conclusions: Exon deletions in SPG4 are as frequent as point mutations, and SPG4 is responsible for 40% of AD-HSP.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

Cited by

References

    1. Hazan J, Fonknechten N, Mavel D, Paternotte C, Samson D, Artiguenave F, Davoine C S, Cruaud C, Durr A, Wincker P, Brottier P, Cattolico L, Barbe V, Burgunder J M, Prud'homme J F, Brice A, Fontaine B, Heilig B, Weissenbach J. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 199923296–303. - PubMed
    1. McDermott C J, Burness C E, Kirby J, Cox L E, Rao D G, Hewamadduma C, Sharrack B, Hadjivassiliou M, Chinnery P F, Dalton A, Shaw P J. Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology 20066745–51. - PubMed
    1. Fonknechten N, Mavel D, Byrne P, Davoine C S, Cruaud C, Bonsch D, Samson D, Coutinho P, Hutchinson M, McMonagle P, Burgunder J M, Tartaglione A, Heinzlef O, Feki I, Deufel T, Parfrey N, Brice A, Fontaine B, Prud'homme J F, Weissenbach J, Durr A, Hazan J. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet 20009637–644. - PubMed
    1. Meijer I A, Hand C K, Cossette P, Figlewicz D A, Rouleau G A. Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia. Arch Neurol 200259281–286. - PubMed
    1. Sauter S, Miterski B, Klimpe S, Bonsch D, Schols L, Visbeck A, Papke T, Hopf H C, Engel W, Deufel T, Epplen J T, Neesen J. Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia. Hum Mutat 200220127–132. - PubMed

MeSH terms